eli lilly retatrutide release date Moves Closer To Another Weight-Loss Drug: Clears Two More Phase 3 Trials Ahead Of FDA Filing Eli Lilly's Next Weight-Loss Drug

Im certainly open to the possibility that these kinds of drugs can have an impact on cognition and aging, says Ronald Petersen, MD, PhD, director of the Mayo Clinic Alzheimers Disease Research Center

An important role is to inactivate incretins (GLP-1 & GIP)

NAD + accumulation may inhibit the phosphorylation of different Tau protein sites by inhibiting the activity of Cdk5-p25 complex

Second, GLP-1R activation enhances neurovascular coupling function, improves cerebral blood flow and repairs BBB integrity, blocking the penetration of peripheral inflammatory factors into the center (Wong et al., 2024)

Third-party tested by Janoshik Analytical